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Background: Breast cancer patients have to face a high-risk state during chemotherapy, which involves deterioration of their
health including extensive physical deterioration. Face-to-face physical exercise programs have presented low adherence rates
during medical treatment, and telehealth systems could improve these adherence rates.
Objective: This study aimed to evaluate the effectiveness of a Web-based exercise program (e-CuidateChemo) to mitigate the
side effects of chemotherapy on the physical being, anthropometric aspects, and body composition.
Methods: A total of 68 patients diagnosed with breast cancer, who were undergoing chemotherapy, were enrolled. The patients
were categorized into two groups: e-CuidateChemo (n=34) and controls (n=34). The e-CuidateChemo group participated in an
adapted 8-week tailored exercise program through a Web-based system. A blinded, trained researcher assessed functional capacity,
strength, anthropometric parameters, and body composition. The intervention effects were tested using analysis of covariance
and Cohen d tests.
Results: Functional capacity improved significantly in the e-CuidateChemo group compared to the control group (6-minute
walk test: 62.07 [SD 130.09] m versus –26.34 [SD 82.21] m; 6-minute walk test % distance predicted: 10.81% [SD 22.69%] m
versus –4.60% [SD 14.58%]; between-group effect: P=.015 for both). The intervention group also showed significantly improved
secondary outcomes such as between-group effects for abdominal (24.93 [SD 26.83] s vs –18.59 [SD 38.69] s), back (12.45 [SD
10.20] kg vs 1.39 [10.72] kg), and lower body (–2.82 [SD 3.75] s vs 1.26 [SD 2.84] s) strength; all P<.001 compared to the control
group.
Conclusions: This paper showed that a Web-based exercise program was effective in reversing the detriment in functional
capacity and strength due to chemotherapy.
Trial Registration: ClinicalTrials.gov NCT02350582; https://clinicaltrials.gov/ct2/show/NCT02350582
(J Med Internet Res 2019;21(7):e14418)  doi: 10.2196/14418
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A diagnosis of cancer is followed by physical and emotional
exhaustion that reduces the quality of life. These functional
impairments seem to be aggravated with surgery and
radiotherapy plus chemotherapy [1] are linked to a decrease in
the level of physical activity of up to 50% [2]. The reduction
in physical activity is not only an important deterioration of
patients’ physical capacity [3], but also associated with
metabolic changes [4], which increase both the recurrence of
cancer and the risk of death [5]. During the treatment, a high-risk
period occurs wherein patients with breast cancer become
especially sensitive; this period involves a deterioration of
health, creating a vicious circle that is difficult to break due to
the physical and psychological state of the patients.
There has been a growing interest in rehabilitation through
physical activity during cancer treatment in the last few years
due to the health related-benefits of such rehabilitation. Patients
undergoing chemotherapy find it challenging to maintain a
physically active lifestyle during their treatment [2], and physical
activity programs following the American College of Sports
Medicine guidelines [6] are accepted as effective, safe, and well
tolerated in patients with breast cancer who are undergoing
chemotherapy [7,8]. These programs focus on aerobic,
resistance, and stretching exercises with a moderate-high
intensity and could successfully address fatigue and quality of
life [9] as well as cardiorespiratory fitness, return to work, and
body composition [10]. Furthermore, there may be a positive
effect of taking part in physical activity programs to optimize
chemotherapy completion rates [11]. It is necessary to emphasize
the potential clinical implications of this fact, because greater
chemotherapy completion rates may improve disease-free and
overall survival [12]. Furthermore, exercise could be the key to
counter the effects of chemotherapy and radiation during
anticancer treatments [13].
Nevertheless, it is not usual for patients with breast cancer to
participate in tailored exercise programs during chemotherapy.
Several barriers to exercise in these patients, such as time
constraints, confusion regarding the safety of returning to
exercise, lack of access to standardized breast cancer–specific
exercise programs, or cancer- and treatment-related side effects
[14], have been identified. The high costs involved in carrying
out on-site physical exercise programs is also linked to this
situation. A recent study showed that an on-site physical activity
program during chemotherapy is not cost-effective for patients
with breast cancer, as such an exercise program accounts for
30% of the total costs [15]. Therefore, alternatives to improve
these difficulties are urgently needed, with programs that can
be adapted according to each patient in terms of intensity and
flexibility.
To combat this issue, current technological advances propose
a real alternative that has already shown encouraging results.
In our recent study, we found that Web-based systems are
effective for improving not only the quality of life, pain, muscle
strength, and fatigue [16], but also the functional capacity and
cognition [17] in survivors of breast cancer. In addition, this
program showed a high rate of adherence (93.9%). In fact, new
Web-based systems are also effective in producing behavior
changes in terms of diet and physical activity [18]. Nevertheless,
few studies have addressed this contemporary topic within the
chemotherapy field, the majority of which are nonrandomized
controlled trials [19-22]. Most previous experiences with
telehealth systems for patients undergoing chemotherapy aimed
at self-management, patient assessment, coaching, or alerting
a clinician [19], but did not seek specific exercise training or
the specific intention to avoid worsening of one’s condition. In
addition, the literature reveals that self-care systems in patients
with chemotherapy are ineffective in managing different
symptoms such as fatigue, and therefore, more intervention
studies are required to evaluate better strategies for support of
cancer patients [23]. A single-arm pilot study [20] proposed a
telephone-based exercise intervention to improve fitness,
psychological, and anthropometric measures. However, the
participants did not receive an adequate tailored intervention
[21], or audiovisual material was used [22].
This randomized controlled trial (RCT) aimed to determine the
effectiveness of an 8-week low-intensity Web-based therapeutic
exercise program for improving the functional capacity, strength,
anthropometric parameters, and body composition of patients
with breast cancer. We hypothesized that the e-CuidateChemo
would prevent the loss of functional capacity and strength and
negative changes in anthropometric parameters and body
composition after the program in patients with breast cancer
undergoing chemotherapy.
Methods
Study Design and Participants
This was a two-arm, assessor-blinded, parallel, efficacy RCT
(ClinicalTrials.gov: NCT02350582) in which 68 patients with
breast cancer undergoing chemotherapy were randomized into
the e-CuidateChemo group (n=34) or the control group (n=34).
The RCT was performed from September 2013 to June 2015
at a physical therapy laboratory at the University of Granada
(Spain). Patients were eligible if they met the following
inclusion criteria: diagnosis of stage I-IIIA breast cancer ,
medical clearance to participate, at the beginning of the
chemotherapy, basic ability to use a computer or living with
someone who could supervise the first steps using the Web, and
having internet access. The participants were excluded if they
had a chronic disease or an orthopedic issue that would interfere
with the ability to participate in a physical activity program and
if they had not provided informed consent.
The Research Ethics Committee of the University of Granada
(FIS PI-0457-2010) approved this trial. This trial was performed
according to the Helsinki Declaration [24] and the Spanish
Biomedical Research Law (14/2007). An oncologist from the
chemotherapy unit of the Hospital Virgen de las Nieves
(Granada) obtained written informed consent from all
participants after the first contact as per the recommendations
[25] and recruited the patients according to the established
criteria.
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After completion of the baseline assessment, the eligible patients
were randomized into either the e-CuidateChemo group or the
control group by using computer-generated numbers (EPIDAT
3.1, Xunta de Galicia Department of Public Department, Coruna,
Spain, and Pan American Health Organization, Washington,
DC). The researcher in charge of the assessments, with several
years of experience with cancer patients, was blinded to the
patients’ randomization (Figure 1). Thereafter, the sequence
was introduced by an external member in sealed opaque
envelopes that were opened after the baseline assessment.
Sample Size Calculation
The sample size and power calculations for this trial were
obtained through the overall functional capacity using the
6-minute walk test (6MWT). This was considered the principal
outcome of this RCT, especially if we take into account the data
reported in a previous study that used a similar online
rehabilitation system [17]. The sample size was set at 68
participants (34 per group), providing a 90% power (with a 5%
significance) and considering a 30% loss to follow-up due to
the specific characteristics of this population. The study
recruitment was completed when the predefined sample size
was reached.
Figure 1. Recruitment and randomization flow diagram process.
Intervention
The e-CuidateChemo Intervention is a telerehabilitation program
that uses an online system [26] adapted to individual
requirements. The system is an 8-week program with three
sessions per week (on nonconsecutive days). Each session was
organized into a warm up, a main, and a cool down part. The
aerobic exercise intensity was between 45% and 60% of the
maximum heart rate [27] and lasted for 15-30 minutes. There
were a total of 5 strength exercises (Table 1 and Textbox 1) of
low intensity with functional implementation. The exercises,
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that is, their volume and intensity, were adapted for each patient
according to the baseline assessment. This online system was
previously used in breast cancer survivors and showed very
high efficiency [16]. As a result, a specific therapeutic exercise
program taking into account the special needs of patients with
breast cancer who are undergoing chemotherapy has now been
developed.
The e-CuidateChemo system also included a communication
system between patients and research staff through an internal
service. The research team controlled whether the participants
received any additional care apart from our intervention.
Moreover, weekly contacts were made to ensure correct
performance of the intervention and to adapt the intervention
to the participants’ chemotherapy cycles.
The control group received the usual care with some written
basic recommendations for physical exercise, following the
general recommendations of the American College of Sports
Medicine [6]. The research team controlled the changes in the
level of physical activity of these participants through the
International Physical Activity Questionnaire. Once the
intervention was complete, the control participants were offered
participation in the same Web-based exercise program as the
intervention group for ethical reasons. No data were recorded
from these patients.
Table 1. Resistance exercises through the e-CuidateChemo telehealth program.




(2×8 repetitions) 30 seconds203
(2×10 repetitions) 30 seconds204
10-13aElastic bands
Training: 1×12 repetitions205
(2×12 repetitions) 30 seconds256
(3×8 repetitions) 30 seconds257
(2×12 repetitions) 30 seconds208
aTwo days with more than a rating of 13 on the Borg scale after training represents a decrease in the intensity of the training program.
Textbox 1. Resistance exercises.
Push up: in standing (wall) or prone position (lying down) with/without support
Squat: lifting arms at 90°
Rowing: in semisquat position
Lunge: front and side
Circular movement of the legs in supine position
Outcomes
All outcomes were assessed at baseline and after the 8-week
program. A clinical and sociodemographic questionnaire was
used for the assessments.
Principal Variable: Functional Capacity
The 6MWT is a useful measure of functional capacity [28]
(H-P-COSMOS for graphics, Germany) [29]. Prior to the test,
all patients were familiarized with the treadmill protocol through
training performed 2 hours before starting the test and with the
period of rest. The participants were instructed to walk as far
as possible for 6 minutes [28]. The 6MWT is an objective and
reliable test (with an intraclass correlation coefficient
[ICC]=0.88) [29]. The results of the 6MWT expressed as percent
predicted values were calculated using the reference equation
described previously by Enright and colleagues [30]. Finally,
participants were distributed for secondary analyses as per their
physical activity capacity (normal vs impaired) by using the
75% cutoff, according to Enright and colleagues [30].
Outcomes Variables
Abdominal Strength
The abdominal endurance was measured with the patient lying
on their back and their knees bent. The patients were instructed
to keep the following position as long as possible: arms lifted
with the palms guided to the level of the knees, avoiding the
lower angle of the scapula from rising from the surface. The
research team encouraged the patients and registered the number
of seconds they held the position (max of 90 seconds). This is
a reliable test with an ICC of 0.97 [31].
Lower-Body Strength
In the multiple sit-to-stand test, participants were asked to sit
down and stand up from a chair 10 times as fast as possible.
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The research staff recorded the length of completion of the test
in seconds, which had a good reliability, with an ICC of 0.80
[32].
Lumbar Strength
The lumbar resistance was evaluated using an analog
dynamometer (TKK 5002 Back-A, Takey, Tokyo, Japan). The
participant was to assume a standing position and maintain a
position of 30 degrees. The test was repeated three times, with
a 1-minute delay between measurements. Finally, the average
of the three measurements was recorded. This test has
demonstrated a high reliability, with an ICC of 0.81-0.85 [33].
Handgrip Strength
A digital dynamometer (TKK 5101 Grip-D, Takey, Tokyo,
Japan) with an adjustable grip was used to measure the
upper-body muscular strength, registering the average score for
each hand (the test was repeated three times with 1-minute delay
between measures). This test is valid and reliable [34].
Anthropometric and Body Composition Outcomes
The waist and hip circumferences were measured using a plastic
tape measure. To assess the waist circumference, the plastic
tape was placed midway between the lower rib margin and the
top of the iliac crest. To measure the hip circumference, the
plastic tape was placed at the level of the greater trochanter.
These measures have demonstrated a high reliability, with ICCs
of 0.89 and 0.81 for the waist and hip circumferences,
respectively [35].
We used bioelectrical impedance (InBody 720, Biospace,
Gateshead, UK) to measure the body composition. The
instrument has a high reliability (ICC=0.98) [36].
Statistical Analysis
A descriptive analysis was performed, and the mean, 95%
confidence interval, and SDs were calculated for each group.
To check the differences between groups at the baseline, we
used the Student t test and Chi-square test. We also used the
Chi-square test to calculate the changes in physical activity
capacity after the intervention. Normal distribution of the
variables was proved with the Shapiro-Wilk test.
Analysis was conducted according to the intention-to-treat
principle (with the worst value carried forward in patients who
had missing data). The intervention effects on study variables
were tested using repeated measure ANCOVA. The time since
diagnosis, age, stage of breast cancer, type of surgery, and
menopausal status were used as covariates. Regarding the level
of significance, interaction effects were reported (5% level of
significance). If the analysis revealed a significant interaction,
we performed pairwise comparisons with the Bonferroni
adjustment to determine if there were differences in the scores
between groups. Moreover, the effect size was calculated using
Cohen d values. The Statistical Program for Social Sciences
(version 22.0; IBM, SPSS Statistic for Windows, Armonk, NY)
was used for statistical analyses.
Results
Sociodemographic and Clinical Data
In summary, 68 patients met the inclusion criteria and were
randomized into either the e-CuidateChemo group (n=34; mean
age 48.82 [SD 7.68]) or the control group (n=34; mean age
47.32 [SD 9.92]). Figure 1 shows the flow chart of patient
distribution and the number and reasons for dropouts. There
were 12 dropouts (35.29%) in the e-CuidateChemo group and
10 dropouts in the control group (29.4%). Moreover, three
participants from the e-CuidateChemo group and four
participants from the control group were excluded from the
main analysis due to missing data. Adherence rate for the
e-CuidateChemo group, calculated as a ratio of the number of
exercise sessions performed in relation to the number of sessions
prescribed, was 73.33%. The sociodemographic and medical
characteristics are shown in Table 2. None of the participants
reported receiving any additional support care in addition to the
study program.
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Table 2. Demographic, clinical, and medical characteristics of the e-CuidateChemo and control groups.
P valueaControl group (n=34)e-CuidateChemo group (n=34)Characteristic
.5947.32 (9.92)48.82 (7.68)Age (years), mean (SD)








.49Employment status, n (%)
2 (9.1)3 (13.6)Housewife
4 (18.2)6 (27.3)Employed
12 (54.5)12 (54.5)Medical leave/unemployed (by illness)
4 (18.2)1 (4.5)Unemployed/retired













.22Menopausal status, n (%)
15 (68.2)11 (50.0)Premenopausal
7 (31.8)11 (50.0)Postmenopausal
.89International Physical Activity Questionnaire score, n (%)
7 (31.8)6 (28.6)Low (<500 METb-min/week)
12 (54.5)11 (52.4)Moderate (500-4499 MET-min/week)
3 (13.6)4 (19.0)High (≥4500 MET-min/week)
aP values for intergroup comparisons using Student t test or Chi-square test, as appropriate.
bMET: metabolic equivalent of task.
Effects of the e-CuidateChemo Intervention on
Functional Capacity
Significant interaction effects were found for both 6MWT
(F1,37=6.51; P=.015) and the percentage of 6MWT prediction
(F1,37=6.44; P=.015). We found a significant difference in favor
of the intervention group for the walked distance and the 6MWT
predicted percentage (both P=.015), with distance and
percentage increasing in the intervention group but decreasing
in the control group. After the intervention, the effect size values
were large for both 6MWT (d=0.83; 95% CI –32.23 to 33.91)
and 6MWT predicted percentage (d=0.83; 95% CI –4.96 to
6.63; Table 3). We found no changes in the results after
inclusion of the covariates.
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Table 3. Within-group and between-group effects for physical outcomes at baseline and after the 8-week intervention. Data are shown as mean (SD)
and 95% CI for the mean at the baseline and after the 8-week intervention and as the mean difference and 95% CI for the differences for within- and
between-group effects.
Between-group effectsControl group (n=20)e-CuidateChemo group (n=19)Parameter
Functional capacity
6-minute walk test (m)
N/Aa480.13 (134.98); 416.96-543.30421.38 (176.53); 36.30-506.47Baseline
N/A453.79 (99.98); 406.99-500.59483.46 (149.37); 411.46-555.458-week intervention
–88.41; –158.64 to –18.18b,c–26.34 (82.21); –64.81 to 12.1362.07 (130.09); –0.63 to 124.77Within-group effect - baseline to 8 weeks
6-minute walk test % predicted (m)
N/A85.23 (23.29); 74.32-96.1374.52 (27.32); 61.35-87.69Baseline
N/A80.62 (16.33); 72.98-88.2785.34 (20.33); 75.54-95.148-week intervention
–15.42; –27.73 to –3.11b,c–4.60 (14.58); –11.42 to 2.2110.81 (22.69); –0.11 to 21.75Within-group effect - baseline to 8 weeks
Strength
Abdominal strength (s)
N/A48.60 (46.07); 27.04-70.1629.01 (27.29); 15.85-42.16)Baseline
N/A30.01 (17.90); 21.63-38.3953.94 (39.03); 35.13-72.768-week intervention
–43.74; –64.88 to –22.60c,d–18.59 (38.69); –36.69 to –0.4824.93 (26.83); 12.00-37.87Within-group effect - baseline to 8 weeks
Lower-body strength (s)
N/A23.23 (3.54); 21.57-24.8924.30 (4.53); 22.11-26.49Baseline
N/A24.50 (4.32); 22.48-26.5221.47 (3.58); 19.74-23.208-week intervention
4.11; 2.01-6.21c,d1.26 (2.84); –0.06 to 2.60–2.82 (3.75); –4.63 to –1.01Within-group effect - baseline to 8 weeks
Back strength (kg)
N/A39.27 (15.14); 32.18-46.3641.05 (15.06); 33.79-48.31Baseline
N/A40.66 (13.88); 34.16-47.1653.50 (16.01); 45.78-61.228-week intervention
–10.59; –17.27 to –3.90b,c1.39 (10.72); –3.62 to 6.4112.45 (10.20); 7.53-17.37Within-group effect - baseline to 8 weeks
Handgrip strength - affected side (kg)
N/A23.76 (3.77); 22.00-25.5323.41 (6.62); 20.21-26.60Baseline
N/A25.08 (4.46); 22.99-27.1625.45 (5.94); 22.58-28.328-week intervention
–0.79; –2.86 to 1.271.31 (3.70); –0.42 to 3.042.04 (2.75); 0.71-3.36Within-group effect - baseline to 8 weeks
Handgrip strength - nonaffected side (kg)
N/A24.72 (4.42); 22.65-26.7924.03 (5.01); 21.61-26.44Baseline
N/A24.70 (4.33); 22.67-26.7324.74 (5.00); 22.32-27.158-week intervention
–0.78; –2.07 to 0.49–0.01 (2.19); –1.04 to 1.010.71 (1.82); –0.16 to 1.59Within-group effect - baseline to 8 weeks
aN/A: not applicable.
bP<.05 (significant between-group effect).
cLarge effect size: Cohen d>0.8.
dP<.001 (significant between-group effect).
Table 4 shows the differences between patients with a normal
physical activity capacity and those with an impaired physical
activity capacity after the intervention. There was an increase
in the number of participants recovering the normal exercise
capacity in the e-CuidateChemo group (45.5% to 78.9%,
pre-postintervention) compared to the decrease in the control
group (73.3% to 65%). Statistical analysis revealed significant
changes between the two groups (P=.02).
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Table 4. Baseline, postintervention, and change in physical exercise capacity. Data are shown as frequencies (percentages) for baseline and postintervention
and as frequency differences for change (including loss to follow-up).









5 (22.7)17 (77.3)12 (54.5)10 (45.5)Baseline, n (%)
7 (35.0)13 (65.0)4 (21.1)15 (78.9)Postintervention, n (%)
2–5–85Changea, n
aImpaired to normal physical exercise capacity.
Effects of the e-CuidateChemo Intervention on Muscle
Strength
The ANCOVA revealed significant interaction effects for
abdominal strength (F1,38=17.55; P<.001) and back strength
(F1,38=10.28; P=.003). The e-CuidateChemo group showed an
increase in abdominal and back strength (both P<.001) after the
intervention compared with the control group, which led to a
decrease in abdominal strength and back strength at the baseline
(Table 3). We also obtained a significant interaction effect for
lower-body strength (F1,38=15.74; P<.001). In this case, the
e-CuidateChemo group showed an improvement in their
lower-body strength after the intervention (P<.001), while the
control group showed similar results at the baseline (Table 3).
The intergroup effect size was large for all variables, namely,
abdominal strength (d=1.33; 95% CI –8.88 to 11.55),
lower-body strength (d=–1.26; 95% CI –2.27 to –0.251), and
back strength (d=1.08; 95% CI –2.11 to 4.28). The inclusion of
the covariates did not change the results of any of the variables.
Regarding the other strength-related measures, handgrip strength
for the affected and nonaffected sides did not reveal significant
interaction effects (F1,38=0.60; P=.44 and F1,38=1.54; P=.22,
respectively).
Effects of the e-CuidateChemo Intervention on
Anthropometric Parameters and Body Composition
The repeated-measure ANCOVA analyses did not show any
significant interaction effects for any of the variables, namely,
waist and hip circumferences, weight, body fat, lean mass, and
body mass index (Table 5).
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Table 5. Within-group and between-group effects for anthropometric and body composition variables at the baseline and after 8-week intervention.
Data are shown as mean (SD) and 95% CI for the mean at baseline and 8-week intervention and as mean differences and 95% CI for the differences
for within- and between-group effects.
Between-groups effectsControl group (n=20)e-CuidateChemo group (n=19)Parameter
Waist circumference (cm)
N/Aa86.10 (8.70); 82.02-90.1785.20 (11.66); 79.81-90.74Baseline
N/A86.28 (10.88); 81.19-91.3786.01 (11.07); 80.83-91.198-week intervention
–0.55; –2.75 to 1.650.18 (3.47); –1.43 to 1.800.73 (3.41); –0.86 to 2.33Within-group effect - baseline to 8 weeks
Hip circumference (cm)
N/A103.82 (8.74); 99.72-107.91101.58 (9.59); 97.08-106.07Baseline
N/A103.50 (9.59); 99.01-107.99102.72 (8.60); 98.69-106.758-week intervention
–1.46; –3.14 to 0.22–0.31 (1.88); –1.19 to 0.561.14 (3.20); –0.35 to 2.64Within-group effect - baseline to 8 weeks
Weight (kg)
N/A67.82 (10.47); 62.91 to 72.7266.46 (12.29); 60.70-72.21Baseline
N/A68.20 (11.71); 62.72 to 73.6867.35 (11.27); 62.07-72.628-week intervention
–0.50; –2.26 to 1.250.38 (2.57); –0.82 to 1.590.89 (2.89); –0.46 to 2.24Within-group effect - baseline to 8 weeks
Body fat (%)
N/A35.01 (7.32); 31.57-38.4332.90 (9.60); 28.41-37.39Baseline
N/A33.13 (6.69); 29.99-36.2633.41 (9.01); 29.19-37.638-week intervention
–2.38; –5.72 to 0.95–1.87 (7.04); –5.17 to 1.420.51 (2.17); –0.50 to 1.52Within-group effect - baseline to 8 weeks
Lean mass (kg)
N/A23.76 (3.15); 22.28-25.2323.84 (2.61); 22.61-25.06Baseline
N/A23.93 (3.32); 22.37-25.4823.93 (2.75); 22.64-25.228-week intervention
0.07; –0.59 to 0.740.17 (1.05); –0.32 to 0.660.09 (1.05); –0.39 to 0.58Within-group effect - baseline to 8 weeks
Body mass index (kg/m2)
N/A26.79 (3.79); 25.01-28.5626.31 (4.97); 23.98-28.63Baseline
N/A26.89 (4.32); 24.87-28.9126.64 (4.58); 24.49-28.788-week intervention
–0.22; –0.90 to 0.450.10 (1.02); –0.37 to 0.580.33 (1.09); –0.18 to 0.84Within-group effect - baseline to 8 weeks
aN/A: not applicable.
Discussion
The results of this RCT show that a Web-based exercise program
is effective in reversing the detriment in functional capacity and
strength, which reflects a physical deterioration normally
experienced by patients with breast cancer who are undergoing
chemotherapy. Having an adequate physical condition during
chemotherapy improves the health state of the patients [37-40],
reduces side effects, allows modulations of the response to
chemotherapy [41], and can even decrease the size of tumors
[42]. Therefore, the findings of this RCT provide evidence about
an adequate support for patients with breast cancer during
chemotherapy.
This therapeutic program involved an improvement, with
significant differences in the walked distance of the 6MWT in
the e-CuidateChemo group as compared to the control group.
The e-CuidateChemo group had a large effect size, showing its
effectiveness despite the low intensities and volumes of aerobic
exercises (up to a maximum of 30 min at 60% of the maximum
heart rate). This increase experienced by the e-CuidateChemo
group in the walked distance is above the smaller change
considered clinically relevant in cancer patients (43.1 m) [43,44].
In our previous randomized trial with breast cancer survivors
[17], a moderate-intensity Web-based exercise program showed
an improvement of 104.84 m after 8 weeks. However, the
program involved more specific training tailored to improve
cardiorespiratory fitness (the American College of Sports
Medicine) and the participants had finished a medical treatment.
Other previous randomized studies on face-to-face exercise
programs also found improvements with aerobic fitness, but all
of them involved more specific and intense aerobic exercise
programs [45]. The current evidence seems to indicate a higher
gain of physical fitness with moderate- or high-intensity exercise
programs [46]. A Web-based support system could be useful
for encouraging patients to avoid the barriers of exercise [47].
It is also important to emphasize the presence of a significant
difference between groups in terms of the 6MWT percentage
predicted, which may also be used to identify the decrease in
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the exercise capacity [30]. We found an increase of 10.8% in
the e-CuidateChemo group (with an average change between
74.5% and 85.3%) and a decrease in the control group (change
from 85.2% to 80.6%). Within the e-CuidateChemo group,
33.4% of patients with breast cancer reached a normal exercise
capacity. In contrast, 12.3% of participants in the control group
reduced their physical exercise capacity after 8 weeks. These
results were slightly lower than those reported in more specific
previous studies [17,45]; in contrast, the results of van Waart
and colleagues [11] confirm that low-level physical exercise
can help minimize the decline in cardiorespiratory fitness. This
fact is very important. Evidence shows that the improvement
of cardiorespiratory fitness could help offset the medical
treatment–related side effects such as heart damage [48,49]. In
addition, it could modulate the response to chemotherapy [41].
Therefore, these data justify the need to integrate such an
intervention in the care routine of patients with breast cancer
during their treatments.
The Web-based exercise program also achieved an improvement
in almost all estimations of muscle strength. The results showed
significant differences in abdominal, lower-body, and back
strength, with a difference of 43.74 s, 4.11 s, and 10.59 kg,
respectively, between both groups. We also found an
improvement of 85.9% (abdominal strength), 11.6% (lower-body
strength), and 29.74% (back strength) in the e-CuidateChemo
group compared with the control group (deterioration of 38.2%
and 5.4% and an improvement of only 3.53%, respectively).
Thus, the e-CuidateChemo program was successful in limiting
the loss of strength of the musculature, which is essential for
the development of daily activities, given its relation to the
ability to move. These results are of vital importance, since
chemotherapy induces wasting, weakness, and muscle fatigue
[50], which could be reflected in the loss of strength or a minor
improvement seen in the control group. Adams and collaborators
[51] showed a reversion of sarcopenia with a
moderate-resistance training program (between 60% and 70%
of the maximum repetition) and a clinical improvement in the
quality of life in patients with breast cancer during
chemotherapy. Surprisingly, our program only has five basic
resistance exercises of low intensity (ratings of 10-13 on the
Borg scale), and these are sufficient to avoid the loss of strength
and even improve it.
We did not find significant differences between groups in our
handgrip strength or lumbar strength results. The constant use
of these muscle in daily activities may have maintained this
muscle in both groups. Furthermore, few exercises of these area
(Table 1 and Textbox 1) were included in our training routine.
The analysis of our results related to anthropometric parameters
and body composition showed a maintenance of these values,
following the same trend in the control group. Kim and
collaborators found a significant reduction of weight, body mass
index, and body fat with a moderate-to-high intensity program
based on walking during 12 weeks (5 consecutive days) [52].
However, our Web-based program was not tailored to improve
these variables. Avoiding poor values related to these variable
could be addressed in future studies, given their influence in
lower physical conditions [53], chemotherapy toxicities [10,54],
recurrence, or mortality [55,56] in patients with breast cancer.
The main strength of this work is that this is the first study, to
our knowledge, that has tested the effectiveness of a
low-intensity exercise program based on a Web-based system,
to improve physical fitness, anthropometric parameters, and
body composition in patients with breast cancer undergoing
chemotherapy. Therefore, this study contributes to the current
knowledge in this field. The e- CuidateChemo system could be
an optimal alternative to support patients with breast cancer,
preventing some of the barriers related to their participation in
physical exercise programs and saving costs as compared to the
high cost of face-to-face programs [15]. Nevertheless, some
limitations should be noted. The use of a treadmill to develop
the 6MWT is questionable due to a possible overestimation,
despite the improvement in terms of percentages predicted in
the walked distance. These results should be considered with
prudence. Finally, a more extended study throughout the
chemotherapy treatment could have produced different results.
Thus, further studies are needed to improve the knowledge in
this field and to examine whether the observed benefits continue
after a long follow-up period.
In conclusion, this low-intensity Web-based exercise program
is effective in reversing the detriment of the functional capacity
and strength in patients with breast cancer undergoing
chemotherapy. The e-CuidateChemo system could be an
excellent option to limit the physical deterioration of patients
with breast cancer undergoing chemotherapy, because it could
prevent the known barriers to practice of physical exercise
during chemotherapy [8].
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